Skip to content
Search

Latest Stories

Additional funding of £91m to boost research in British universities    

THE UK will spend an additional £91 million for research, taking the annual budget allocations for university-led research to a record high.

With additional spending, the universities in Britain will receive £2.2 billion in the 2019-20 academic year to support their research and development (R&) activities.


The sum for university research was announced today (2) by Research England in its annual budget allocations.

The funding forms part of the government’s overall aim to boost spending on R&D to 2.4 per cent of GDP by 2027; the UK’s highest recorded level ever.

Additional funding includes a real-terms uplift of 2.3 per cent for mainstream quality-related (QR) research funding.

The additional funding will give universities more capacity to invest in the people, partnerships and infrastructure that are essential for delivering cutting-edge research that brings real-world benefits.

Universities minister Chris Skidmore said: “…this announcement today marks an important recognition of university research and the need to invest more in flexible, curiosity-driven research that has tremendous benefits to developing our international standing as a research powerhouse.

“Increased investment in research and development is a key ambition of the government which has committed to 2.4 per cent GDP spent on R&D by 2027 – a vital part of our industrial strategy. The government has already committed to investing an additional £7bn on R&D by 2021, the largest increase for forty years.”

Commenting on the announcement of £91m in additional university-driven research funding, including a £45m increase in QR funding, Alistair Jarvis, chief executive of Universities UK, said: “Quality-related research funding plays a key role in developing new talent, strengthening research culture and building the skilled workforce the UK needs if we are to perform effectively as a modern knowledge economy...”

The latest increase in funding includes additional contributions from the National Productivity Investment Fund (NPIF), supporting universities to implement the government’s industrial strategy.

More For You

pharmaceuticals

UK becomes the only country in the world to have secured a zero per cent tariff rate for pharmaceutical shipments

iStock

UK secures zero-tariff deal with US on pharmaceuticals

Highlights

  • UK pharmaceutical exports worth £5bn annually protected from US tariffs for three years.
  • NHS spending on medicines to double from 0.3 per cent to 0.6 per cent of GDP over next decade.
  • Deal safeguards jobs at major British drugmakers including GSK and AstraZeneca.
The UK has secured a landmark deal with the United States guaranteeing zero tariffs on pharmaceutical exports. The UK government said it was the only country in the world to have secured a zero per cent tariff rate for pharmaceutical shipments.

Under the agreement announced on Monday, the NHS will pay more for medicines in return for a three-year guarantee that US import taxes on pharmaceuticals made in Britain will remain at zero per cent.

The deal comes after US President Donald Trump threatened to raise tariffs to as high as 100 per cent on branded drug imports, raising alarm for major British drugmakers including GSK and AstraZeneca.

Keep ReadingShow less